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ABSTRACT
PURPOSE: To perform a cost analysis of simultaneous pancreas-kidney transplantation (SPKT) in a Brazilian hospital.
METHODS: Between January 2008 and December 2011, 105 consecutive SPKTs at the Hospital of Kidney and Hypertension in Sao 
Paulo were evaluated. We evaluated the patient demographics, payment source (public health system or supplementary system), and 
the impact of each hospital cost component. The evaluated costs were corrected to December 2011 values and converted to US dollars.
RESULTS: Of the 105 SPKT patients, 61.9% were men, and 38.1% were women. Eight patients died, and 97 were discharged (92.4%). 
Eighty-nine procedures were funded by the public health system. The cost for the patients who were discharged was $18.352.27; the 
cost for the deceased patients was $18.449.96 (p = 0.79). The FOR for SPKT during this period was positive at $5,620.65. The costs 
were distributed as follows: supplies, 36%; administrative costs, 20%; physician fees, 15%; intensive care unit, 10%; surgical center, 
10%; ward, 9%.
CONCLUSION: Mortality did not affect costs, and supplies were the largest cost component.
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Introduction 
The first pancreas transplant in the world was performed 
in 1966 in the United States by surgeons William D. Kelly and 
Richard C. Lillehei at the Hospital of the University of Minnesota 
in Minneapolis1. This surgery was a duodenum/pancreas 
transplantation simultaneously with kidney transplantation. Since 
then, simultaneous pancreas-kidney transplantation has evolved 
technically, and with the development of new immunosuppressive 
therapy, this technique has become an efficient and accepted 
method for managing patients with end-stage renal disease and 
diabetes mellitus throughout the world2.
Simultaneous pancreas-kidney transplantation (SPKT) 
has a higher technical complication rate compared with other 
transplants, which increases the cost of the procedure. The Brazilian 
health system has two types of health insurance: a public health 
system (i.e., Unique Health System, SUS) and a supplementary 
system (SS); the majority of patients belong to the former. It is 
important to transplant teams, institutions, and the health system 
to assess the economic viability of SPKT.
Few data are available regarding the finances of SPKT. 
Gruessner et al.3 evaluated the risk factors associated with 
increased hospital charges for pancreas transplantation and stated a 
need for a hospital cost analysis. The objective of the current study 
was to perform a cost analysis of SPKT in a Brazilian hospital, 
including demographic variables, payment source (SUS or SS), 
and the impact of each hospital cost component.
Methods
After receiving approval from the institutional ethics 
committee and following the principles outlined in the Declaration 
of Helsinki, records from 105 SPKTs performed between January 
1, 2008 and December 31, 2011 at the Hospital of Kidney and 
Hypertension in Sao Paulo were retrospectively reviewed. Clinical 
data, including hospital time, complications, and other information 
were obtained from the medical records.
Inpatient financial data concerning the combined 
physician procedural and nonprocedural reimbursements and 
total hospital costs (direct and indirect) were obtained from the 
internal cost accounting database at the Hospital of Kidney and 
Hypertension. The costs included SPKT admissions without pre- 
and postoperative evaluations. All pharmaceutical costs, including 
prolonged inpatient and outpatient intravenous antibiotics, were 
incorporated into the financial data. Financial data were collected 
from the day of transplantation (including the transplant operation) 
until the day that the patient was discharged. The data were 
analyzed separately for each of the two Brazilian health systems 
(SUS and SS).
All costs were evaluated monthly, converted to dollars, 
and then corrected to the official dollar value for December 2011, 
according to the IPCA and the IBGE; therefore, the values are 
expressed in US dollars and as medians. 
Statistical analysis
The relationships among the variables were assessed 
using an unpaired Student’s t-test for continuous variables and 
a chi-squared analysis for categorical variables. Differences in 
financial data medians were assessed using the Mann-Whitney 
U-test. All statistical analyses were performed using StatView 
(version 5.0.1) (Abacus Concepts, Inc., Berkley, CA, USA).
Results
There were no significant age differences between the 
patients who were discharged and those who died. Men comprised 
a relatively higher percentage of patients, and there were no 
significant cost differences based on gender.
There was a significant difference in the mean total cost 
between the two payment sources, p=0.007 (Table 1).
N Total Cost Mean Variance Standard 
Deviation
SS 16 402.860.4 25.178.7 59182422.0 7693.0
SUS 89 1.775.147.6 19.945.4 51612832.4 7184.2
TABLE 1 - Mean cost per payment source (values in US 
dollars).
Eight patients died, and 97 were discharged (92.4%). 
All death cases were observed in the public health system (SUS) 
group. Death was not associated with significantly increased 
hospital charges, costs and reimbursements. The mean cost for the 
patients who were discharged was $18.352.27, and the mean cost 
for those who died was $18.449.96 (p=0.79).
The length of stay in the ward was 8.35 days at a mean 
cost of $1484.72, representing 10% of the total cost, with no 
difference between the two payment sources. The length of ICU 
stay represented 10% of the cost, with a mean of 3.05 days at 
a cost of $1398.05. Supplies were the major cost component, 
accounting for 36% of the total cost, with an average value of 
$ 6.172. The distribution of the percentages and the component 
costs is presented in Figure 1.
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The surgical time of 6.33 hours cost $1876.62 and, along 
with the intensive care unit (ICU) and hospital stays, represented 
the lower-cost components; in contrast, supplies and administration 
were higher cost components.
Table 2 compares the cost per component for each of the 
payment sources. Although there are cost differences (mainly at the 
supply level), these differences were not statistically significant.
transplantation but noted the need for a detailed financial analysis. 
Englebese et al.6 investigated the influence of 
postoperative complications on the financial results of pancreas 
transplantation based on three variables; the authors found a 
$15.514 difference between the patients with complications and 
without complications. The financial cost was higher for the 
patients who presented with surgical complications, at a cost of 
$17.363; the authors concluded that transplant surgical quality 
improvement might benefit patients and costs6. In our study, the 
only complication measured was death, and no cost difference 
was found when the deceased patients were compared with the 
patients discharged alive. 
Of the eight patients who died, the causes were sepsis 
(n=4), cardiovascular events (n=3), and hemorrhagic shock (n=1). 
It is possible that there is no cost difference between the deceased 
patients and those who were discharged because early deaths 
shortened the hospitalizations of these patients.
There are different cost components for pancreas 
transplantation. We found no other studies in which these 
components were analyzed individually. Our findings demonstrated 
a great difference in the cost of supplies and administration vs the 
cost of medical and nursing care, which is most likely caused 
by the enormous amount of logistics required for SPKT and the 
associated high cost.  
Vonlanthen et al.7 performed a cost study of patients who 
underwent major surgeries (i.e., liver, pancreas, colorectal and 
gastric bypass surgeries); the objective was to determine the impact 
of surgical and post-surgical complications during the hospital 
stay on the final financial outcome. The authors demonstrated that 
postoperative complications greatly impact the financial costs and 
outcomes of the procedure (p=0.001). 
There was also a higher cost for SPKT in patients with 
SS, and the difference was significant; however, the FOR margin 
was higher in this group. We believe that the lower gain margin in 
the SUS is offset by the high volume of this patient group. Cohn et 
al.8 found similar data in their study, which described a higher cost 
of complications for patients with Medicare insurance.
Conclusions
Simultaneous pancreas-kidney transplantation (SPKT) 
is an economically viable process for Brazilian health institutions. 
The mortality rate does not indicate an increase in costs for the 
procedure. The highest cost is for medical supplies. It is necessary to 
assess the impact of all complications to analyze the cost of SPKT.
FIGURE 1 - Percentage distribution of costs by component.
SUS SS Difference
Supplies 6.851.67 10.630.38 -3.778.71
Administrative costs 3.989.1 5.035.76 -1.046.66
Surgeons’ Fees 3.120.14 3.132.57 -12.43
Ward 2.037.41 2.366.38 -328.97
ICU 2.037.86 1.827.61 210.25
Surgical center 1.909.29 2.186.08 -276.79
TABLE 2 - Financial data of patients with SUS vs. SS 
per component (values in dollars).
To study the economic feasibility of the procedure, the 
billing was compared to the procedure cost and was analyzed by 
separating the data by the payment source. The FOR was positive for 
both groups and averaged $5620.65. However, when differentiating 
between the payment sources, a higher gain was found in the SUS; 
this difference was statistically significant (p=0.002).
Discussion
To establish the economic feasibility of SPKT, it is to 
measure its costs and profits. In a systematic literature search of 
United States, European, and Latin American publications, little 
data are available concerning the finances of SPKT. Troppman 
et al.5 studied the complication rates associated with pancreas 
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